RS
Renjith Sasidharan Nair
About Renjith Sasidharan Nair
Data last updated:
Renjith Sasidharan Nair is a Director at Opiate Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Opiate Pharmaceuticals Private Limited reported revenue of ₹14.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Opiate Pharmaceuticals Private Limited U46497KL2023PTC084389 | Director | 06 Nov 2023 | 2023 | ₹14.6 Lakh (FY 2025) | Active |
Board colleagues of Renjith Sasidharan Nair
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tony Joseph | 08044080 | Opiate Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Renjith Sasidharan Nair
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renjith Sasidharan Nair
Renjith Sasidharan Nair currently holds 1 directorship: Opiate Pharmaceuticals Private Limited (Director, since 06 Nov 2023, revenue ₹14.6 Lakh (FY 2025)).
Renjith Sasidharan Nair was first appointed on 06 Nov 2023 as Director at Opiate Pharmaceuticals Private Limited.
The current boards of Renjith Sasidharan Nair's companies include Tony Joseph (Opiate Pharmaceuticals Private Limited).